BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 ,inter alia, to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, 30th May 2022, to approve the accounts of the Company for the quarter and year ended 31st March 2022.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

08 Apr 2022

21.00

-0.05%

Company Update

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Statement Of Investor Complaints For The Quarter Ended March 2022

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- SANDIP KUMAR LALDesignation :- Company Secretary and Compliance Officer

Bharat Immunological & Biologicals Corporation Ltd.

09 Feb 2022

21.00

-0.05%

Result

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Submission Of Limited Review Report Of The …

BSE India

In pursuance of Regulation 33(3) (C ) of the LODR with Stock Exchange, please find enclosed the Limited Review Report along with the financial results for the Quarter ended 31st December 2021. It is requested to kindly take the above on record please.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

09 Feb 2022

21.00

-0.05%

Result

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Board Meeting Outcome for Submission Of Unaudited …

BSE India

In pursuance of the LODR with Stock Exchange, please find enclosed the Unaudited quarterly financial results for the quarter ended December 2021 approved by the Board of the Company in its Meeting on 08.02.2022. The XBRL filing will be made succeeding to this.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

31 Jan 2022

21.00

-0.05%

Board Meeting

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Board Meeting Intimation for Intimation Of Date …

BSE India

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2022 ,inter alia, to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 8th February 2022, to approve the accounts of the Company for the quarter ended 31st December 2021.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

31 Jan 2022

21.00

-0.05%

Company Update

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Shareholding for the Period Ended December 31, 2021

BSE India

Bharat Immunologicals & Biologicals Corporation Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here

Bharat Immunological & Biologicals Corporation Ltd.

10 Jan 2022

21.00

-0.05%

Company Update

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ - 524663 - Statement Of Investor Complaints For The Quarter Ended December 2021

BSE India

Bharat Immunological & Biologicals Corporation Ltd.

01 Dec 2021

21.00

-0.05%

AGM

Bharat Immunologicals & Biologicals Corporation Ltd - 524663 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

BSE India

Bharat Immunologicals & Biologicals Corporation Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here

Is Bharat Immunological & Biologicals Corporation Ltd. worth buying?

135 Votes:

Buy 69.63%

Sell 14.81%

Hold 15.56%

41.47% Fall from 52W High

Bharat Immunological & Biologicals Corporation Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Bharat Immunological & Biologicals Corporation Ltd. on BSE